Finnish self-adhesive label materials supplier UPM Raflatac has announced the opening of its labelstock slitting and distribution terminal in Vietnam. UPM Raflatac Southeast Asia general manager Jouni Komulainen said since November 2012, ...
Holfeld Plastics has developed an auto de-nestable range of punnets across its standard crate fit G81 portfolio, for the soft fruit packaging industry. The 'one size fits all' G81 auto de-nest punnet range, from the Irish rigid packaging ...
US-based polysilicon maker MEMC has reported first-quarter 2013 financial results with net sales of US$443.6 million, down 26% on quarter and 15% on year. The firm reported first-quarter gross margin of 11.2%, lower than 18% in the fourth ...
The USFDA has approved Novartis' Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients with two years age and more. The first interleukin-1 beta inhibitor is the only treatment approved ...
GlaxoSmithKline (GSK) and Theravance have announced the FDA approval of Breo Ellipta as maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The inhaled long-term, once-daily maintenance ...
Tags: GSK, Theravance, Copd Therapy
The US FDA has expanded the indication for the Medicines Company's Recothrom for use in children greater than or equal to one month of age. The recombinant topical thrombin is indicated to aid hemostasis whenever oozing blood and minor ...
Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
Cubist Pharmaceuticals has received the US Food and Drug Administration (FDA) fast track status for its late-stage antibiotic candidate ceftolozane/tazobactam in the previously granted Qualified Infectious Disease Product (QIDP) ...
Tags: Cubist, Fast Track Status
Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...
Tags: Curis, Erivedge Anti-Cancer Drug
Warner Chilcott has announced US FDA approval of norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, new oral contraceptive. The company expects to make the product available in early August 2013. ...
Pfizer has launched its counterfeit medicine Viagra (sildenafil citrate) tablets home delivery, a new prescription-fulfillment website for Viagra. Powered by CVS/pharmacy and accessible through Viagra.com, the site offers men with ...
Tags: Pfizer, Viagra Tablets
Cornerstone Therapeutics has signed an agreement to acquire exclusive US marketing rights to Pertzye (pancrelipase) from Digestive Care (DCI). Pertzye, the pancreatic enzyme product, is indicated for the treatment of exocrine pancreatic ...
Tags: Cornerstone, Digestive Care
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
All too often, bathrooms can become cluttered with seemingly hundreds of bottles of lotions and potions everywhere, making the room look incredibly untidy. However, a bit of organisation and appropriate storage - combined with a flattering ...
The prestigious educational institution Bath University has just strengthened its position as one of the best establishments in the country by installing a truly state-of-the-art lighting system. Across the campus, the new lights will be ...
Tags: Lighting Overhaul, Lighting